Augustin Ferrant is a scholar working on Hematology, Genetics and Oncology.
According to data from OpenAlex, Augustin Ferrant has authored 225 papers receiving a total of 10.9k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Hematology, 72 papers in Genetics and 50 papers in Oncology. Recurrent topics in Augustin Ferrant's work include Acute Myeloid Leukemia Research (60 papers), Chronic Lymphocytic Leukemia Research (45 papers) and Hematopoietic Stem Cell Transplantation (39 papers). Augustin Ferrant is often cited by papers focused on Acute Myeloid Leukemia Research (60 papers), Chronic Lymphocytic Leukemia Research (45 papers) and Hematopoietic Stem Cell Transplantation (39 papers). Augustin Ferrant collaborates with scholars based in Belgium, France and Germany. Augustin Ferrant's co-authors include Leo F. Verdonck, Per Ljungman, William Arcese, Bernd Hertenstein, Dietger Niederwieser, A Schattenberg, JM Goldman, HJ Kolb, N Jacobsen and André Bosly and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.
In The Last Decade
Augustin Ferrant
219 papers
receiving
10.6k citations
Hit Papers
What are hit papers?
Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]
19951.5k citationsAugustin Ferrant, Leo F. Verdonck et al.Bloodprofile →
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
2009596 citationsBob Löwenberg, Harry C. Schouten et al.profile →
Author Peers
Peers are selected by citation overlap in the author's most active subfields.
citations ·
hero ref
Countries citing papers authored by Augustin Ferrant
Since
Specialization
Citations
This map shows the geographic impact of Augustin Ferrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Augustin Ferrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Augustin Ferrant more than expected).
Fields of papers citing papers by Augustin Ferrant
This network shows the impact of papers produced by Augustin Ferrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Augustin Ferrant. The network helps show where Augustin Ferrant may publish in the future.
Co-authorship network of co-authors of Augustin Ferrant
This figure shows the co-authorship network connecting the top 25 collaborators of Augustin Ferrant.
A scholar is included among the top collaborators of Augustin Ferrant based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Augustin Ferrant. Augustin Ferrant is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lübbert, Michael, Augustin Ferrant, P. Wijermans, et al.. (2000). Cytogenetic remissions in high-risk myelodysplastic syndrome: Results in 124 patients treated with low-dose 5-aza-2 '-deoxycytidine (Decitabine), a DNA methylation inhibitor.. Blood. 96(11).3 indexed citations
3.
Michaux, Lucienne, Augustin Ferrant, Anne Hagemeijer, et al.. (1998). Cytogenetic abnormalities in Waldenstrom's disease (WD): A single centre study on 45 cases.. Blood. 92(10).8 indexed citations
4.
Lecouvet, Frédéric, Lucienne Michaux, Augustin Ferrant, et al.. (1997). Spinal bone marrow magnetic resonance imaging (MRI) in stage III multiple myeloma (MM): Correlation with clinical, laboratory and histologic findings, with initial response to treatment and with patient survival.. Blood. 90(10). 1562–1562.1 indexed citations
Lecouvet, Frédéric, Bruno Berg, Lucienne Michaux, et al.. (1996). Magnetic resonance (MR) imaging of the bone marrow to assess the risk of disease progression in patients with stage I multiple myeloma. British Journal of Haematology. 93. 1138–1138.1 indexed citations
8.
Lecouvet, Frédéric, Bruno Berg, Lucienne Michaux, et al.. (1996). Magnetic resonance (MR) imaging of the bone marrow to assess the risk of disease progression in patients with monoclonal gammapathy of undetermined significance (MGUS). British Journal of Haematology. 93. 1137–1137.1 indexed citations
9.
Herman, Philippe, Augustin Ferrant, Jl. Michaux, Marc De Bruyère, & Nicole Straetmans. (1995). Ex-vivo Expansion of Normal Human Bone-marrow Cd34+dr(low) Cells in Liquid Culture. Experimental Hematology. 23(8). 908–908.1 indexed citations
10.
Bosly, André, Augustin Ferrant, Anne Sonet, et al.. (1995). 2-Chlorodeoxyadenosine in refractory non-Hodgkin's lymphoma: A phase II study on 50 patients.. Blood. 86(10). 212–212.4 indexed citations
11.
Lecouvet, Frédéric, Augustin Ferrant, Jacques Malghem, et al.. (1995). Sequential quantitative magnetic resonance imaging of the bone marrow to assess treatment response in patients with acute leukemia. Blood. 86(10). 3126–3126.1 indexed citations
12.
Neste, Eric Van Den, Augustin Ferrant, Marie Maerevoet, et al.. (1994). Cyclosporine-a (cy A) Has Only Marginal Antileukemic Activity in Refractory Chronic Lymphocytic-leukemia (cll). Blood. 84(10).1 indexed citations
13.
Delannoy, André, Augustin Ferrant, Philippe Martiat, et al.. (1994). 2-chlorodeoxyadenosine (cda) for Previously Untreated Chronic Lymphocytic-leukemia (cll). Blood. 84(10).3 indexed citations
14.
Neste, Eric Van Den, Augustin Ferrant, André Delannoy, et al.. (1993). 2-chloro-deoxyadenosine With Or Without Daunorubicin for Relapsing Or Refractory Acute Myeloblastic-leukemia. Blood. 82(10).1 indexed citations
15.
Bosly, André, Augustin Ferrant, André Delannoy, et al.. (1993). 2-chlorodeoxyadenosine Therapy in Non-hodgkins-lymphoma. Blood. 82(10).2 indexed citations
16.
Filleul, Bertrand, Augustin Ferrant, André Delannoy, et al.. (1993). A Single Course of 2-chloro-deoxyadenosine (2-cda) Does Not Eradicate Leukemic-cells in Hairy-cell Leukemia (hcl) Patients Achieving Complete Remission. Blood. 82(10).3 indexed citations
17.
Jamar, François, Augustin Ferrant, N. Leners, & Daniel Labar. (1992). [2-c-11]-thymidine Pet Scan in Non-hodgkin Lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 19(8). 693–693.1 indexed citations
18.
Martiat, P., et al.. (1990). Entéropathie exsudative causée par une réaction aiguë du greffon contre l'hôte. A propos d'une observation.. Acta gastro-enterologica belgica. 53(5). 488–498.1 indexed citations
19.
Ferrant, Augustin, et al.. (1985). Cyclosporin-a Induced Hypertension in Bone-marrow Transplantation. Kidney International. 28(2). 394–394.6 indexed citations
20.
Ferrant, Augustin. (1983). The Role of the Spleen in Hemolysis. Clinical Obstetrics & Gynecology. 12(2). 489–504.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.